The Beauty Health Company (SKIN)

The Beauty Health Company Stock Forecast

Stock Price Forecast

The 4 analysts that cover The Beauty Health Company stock have a consensus rating of "Buy" and an average price target of $2.03, which forecasts a 130.42% increase in the stock price over the next year. The lowest target is $1.50 and the highest is $3.50.

Price Target: $2.03 (+130.42%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$1.50	$2.03	$1.60	$3.50
Change	+70.26%	+130.42%	+81.61%	+297.28%

* Price targets were last updated on Mar 16, 2026.

Analyst Ratings

The average analyst rating for The Beauty Health Company stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	2	2	3	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Oliver Chen TD Cowen	TD Cowen	Hold Maintains $1.65 → $1.5	Hold	Maintains	$1.65 → $1.5	+70.26%	Mar 16, 2026
Susan Anderson Canaccord Genuity	Canaccord Genuity	Hold Maintains $1.5	Hold	Maintains	$1.5	+70.26%	Mar 13, 2026
Oliver Chen TD Cowen	TD Cowen	Hold Maintains $1.5 → $1.65	Hold	Maintains	$1.5 → $1.65	+87.29%	Jan 21, 2026
Sydney Wagner Jefferies	Jefferies	Hold Initiates $1.6	Hold	Initiates	$1.6	+81.61%	Jan 14, 2026
Oliver Chen TD Cowen	TD Cowen	Hold Maintains $2 → $2.5	Hold	Maintains	$2 → $2.5	+183.77%	Sep 22, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

303.45M

Increased by 0.88%

from 300.79M

Revenue Next Year

317.42M

Increased by 4.60%

from 303.45M

EPS This Year

-0.14

from -0.16

EPS Next Year

-0.13

from -0.14

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	260.09M	365.88M	397.99M	334.29M	300.79M	303.45M	317.42M
Revenue Growth	118.39%	40.68%	8.78%	-16.01%	-10.02%	0.88%	4.60%
EPS	-3.71	-0.23	-0.76	-0.36	-0.16	-0.14	-0.13
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	11	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2032
High	320.4M	340.7M
Avg	303.5M	317.4M
Low	285.2M	296.1M

Revenue Growth

Revenue Growth	2026	2027	2028	2032
High	6.5%	12.3%
Avg	0.9%	4.6%
Low	-5.2%	-2.4%

EPS Forecast

EPS	2026	2027	2028
High	0.07	0.06
Avg	-0.14	-0.13
Low	-0.30	-0.21

EPS Growth

EPS Growth	2026	2027	2028
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.